CellFE
Microfluidics Technology Developer / Cell Therapy Manufacturing – OEM
Goals & Objectives
CellFE is a venture capital-backed technology provider that developed a proprietary microfluidics platform capable of rapidly engineering cells with high yields and quality, enabling complex genome editing and scalable cell therapy manufacturing. CellFE’s backers encouraged them to engage That’s Nice to develop a strong go-to-market strategy and evolve its brand ahead of a make-or-break Series A funding round.
Strategic Approach
That’s Nice collaborated directly with CellFE’s Founder & CEO, technical SMEs, and VC company to advance the strategic vision that would shape the brand, including memory trigger messaging to build awareness, digital assets, and sales team support.
Meeting & Exceeding KPIs
In just over 4 months, we optimized investor and customer engagement, with the crescendo of a significant launch at the ASGCT trade show. CellFE went on to secure $22 Million in Series A funding, supporting a 24-month runway for its next stages of development and commercialization.
